The regulatory status of tirzepatide in the united kingdom involves careful distinction among two unique categories:In the UK, tirzepatide is licensed from the MHRA as Mounjaro for the treatment of variety 2 diabetes mellitus and, subsequently, for excess weight management in Older people wi